Lack of Evidence for a Relationship between High Risk Human Papillomaviruses and Breast Cancer in Iranian Patients

  • Doosti, Masoud (Department of Animal Viral Disease Research and Diagnosis, Razi Vaccine & Serum Research Institute) ;
  • Bakhshesh, Mehran (Department of Animal Viral Disease Research and Diagnosis, Razi Vaccine & Serum Research Institute) ;
  • Zahir, Shokouh Taghipour (Clinical and Surgical Pathology, Shahid Sadooghi University of Medical Science) ;
  • Shayestehpour, Mohammad (Department of Virology, School of Public Health, Tehran University of Medical Sciences) ;
  • Karimi-Zarchi, Mojgan (Department of Obstetrics and Gynecology, Shahid Sadooghi University of Medical Science)
  • 발행 : 2016.09.01

초록

Background: Whether there is any relationship between human papilloma virus (HPV) and breast carcinoma is not clear. Some previous studies have indicated a possible role in oncogenesis in the breast. In this study, we therefore analyzed the presence of HPV infection in breast tissues of Iranian women from Yazd city. Materials and Methods: In a cross-sectional study, formalin-fixed paraffin-embedded tissues from 87 patients with breast cancer and 84 cases with breast fibrocystic lesions (control group) were selected from a tissue archive. Grade of tumors and fibrocystic tissues were determined by two pathologists. The nested-PCR method was performed for detection of HPVs in samples. HPV genotypes were determined by sequencing and the phylogenetic tree depicted by MEGA software. Results: Of the 87 women with breast cancer, 22.9% (20 isolates) had positive results for HPV DNA. In the control group no HPV was detected. The HPV genotypes in positive samples were HPV-16 (35%) HPV-18 (15%), HPV-6 (45%) and HPV-11 (5%). The data did not approved a significant correlation between tissue pathology of breast cancer and the HPV genotype frequency. Conclusions: The data did not provide any evidence for a role of high risk HPV types in oncogenesis in the breast.

키워드

참고문헌

  1. (2004). Global battle against cancer won't be won with treatment alone--effective prevention measures urgently needed to prevent cancer crisis. Cent Eur J Public Health, 22, 23, 8.
  2. Ahangar-Oskouee M, Shahmahmoodi S, Jalilvand S, et al (2014). No detection of 'high-risk' human papillomaviruses in a group of Iranian women with breast cancer. Asian Pac J Cancer Prev, 15, 4061-5. https://doi.org/10.7314/APJCP.2014.15.9.4061
  3. Alibek K, Kakpenova A, Mussabekova A, et al (2013). Role of viruses in the development of breast cancer. Infect Agent Cancer, 8, 32. https://doi.org/10.1186/1750-9378-8-32
  4. Baker SG (2015). RE: Combined Associations of Genetic and Environmental Risk Factors: Implications for Prevention of Breast Cancer. J Natl Cancer Inst, 107.
  5. Chlebowski RT, Anderson GL (2015). Menopausal hormone therapy and breast cancer mortality: clinical implications. Ther Adv Drug Saf, 6, 45-56. https://doi.org/10.1177/2042098614568300
  6. Damin AP, Karam R, Zettler CG, et al (2004). Evidence for an association of human papillomavirus and breast carcinomas. Breast Cancer Res Treat, 84, 131-7. https://doi.org/10.1023/B:BREA.0000018411.89667.0d
  7. de Cremoux P, Thioux M, Lebigot I, et al (2008). No evidence of human papillomavirus DNA sequences in invasive breast carcinoma. Breast Cancer Res Treat, 109, 55-8. https://doi.org/10.1007/s10549-007-9626-4
  8. de Martel C, Ferlay J, Franceschi S, et al (2012). Global burden of cancers attributable to infections in 2008: a review and synthetic analysis. Lancet Oncol, 13, 607-15. https://doi.org/10.1016/S1470-2045(12)70137-7
  9. Di Lonardo A, Venuti A, Marcante ML (1992). Human papillomavirus in breast cancer. Breast Cancer Res Treat, 21, 95-100. https://doi.org/10.1007/BF01836955
  10. Dossus L, Benusiglio PR (2015). Lobular breast cancer: incidence and genetic and non-genetic risk factors. Breast Cancer Res, 17, 37. https://doi.org/10.1186/s13058-015-0546-7
  11. Fu L, Wang D, Shah W, et al (2015). Association of human papillomavirus type 58 with breast cancer in shaanxi province of China. J Med Virol, 87, 1034-40. https://doi.org/10.1002/jmv.24142
  12. Gradishar WJ, Anderson BO, Balassanian R, et al (2015). Breast cancer version 2.2015. J Natl Compr Canc Netw, 13, 448-75. https://doi.org/10.6004/jnccn.2015.0060
  13. Gumus M, Yumuk PF, Salepci T, et al (2006). HPV DNA frequency and subset analysis in human breast cancer patients' normal and tumoral tissue samples. J Exp Clin Cancer Res, 25, 515-21.
  14. Hennig EM, Suo Z, Karlsen F, et al (1999a). HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasia (CIN III). Acta Oncol, 38, 639-47. https://doi.org/10.1080/028418699431258
  15. Hennig EM, Suo Z, Thoresen S, et al (1999b). Human papillomavirus 16 in breast cancer of women treated for high grade cervical intraepithelial neoplasia (CIN III). Breast Cancer Res Treat, 53, 121-35. https://doi.org/10.1023/A:1006162609420
  16. Hsu CR, Lu TM, Chin LW, et al (2010). Possible DNA viral factors of human breast cancer. Cancers (Basel), 2, 498-512. https://doi.org/10.3390/cancers2020498
  17. Hvidtfeldt UA, Tjonneland A, Keiding N, et al (2015). Risk of breast cancer in relation to combined effects of hormone therapy, body mass index, and alcohol use, by hormonereceptor status. Epidemiology, 26, 353-61. https://doi.org/10.1097/EDE.0000000000000261
  18. Imtiaz S, Siddiqui N (2014). Vitamin-D status at breast cancer diagnosis: correlation with social and environmental factors and dietary intake. J Ayub Med Coll Abbottabad, 26, 186-90.
  19. Kan CY, Iacopetta BJ, Lawson JS, et al (2005). Identification of human papillomavirus DNA gene sequences in human breast cancer. Br J Cancer, 93, 946-8. https://doi.org/10.1038/sj.bjc.6602778
  20. Kwong A, Leung CP, Shin VY, et al (2013). No Evidence of Human Papillomavirus in Patients with Breast Cancer in Hong Kong, Southern China. ISRN Virology, 2013.
  21. Li N, Bi X, Zhang Y, et al (2011). Human papillomavirus infection and sporadic breast carcinoma risk: a metaanalysis. Breast Cancer Res Treat, 126, 515-20. https://doi.org/10.1007/s10549-010-1128-0
  22. Lindel K, Forster A, Altermatt HJ, et al (2007). Breast cancer and human papillomavirus (HPV) infection: no evidence of a viral etiology in a group of Swiss women. Breast, 16, 172-7. https://doi.org/10.1016/j.breast.2006.09.001
  23. Marchina E, Fontana MG, Speziani M, et al (2010). BRCA1 and BRCA2 genetic test in high risk patients and families: counselling and management. Oncol Rep, 24, 1661-7.
  24. Molah Karim SA, Ali Ghalib HH, Mohammed SA, et al (2015). The incidence, age at diagnosis of breast cancer in the Iraqi Kurdish population and comparison to some other countries of Middle-East and West. Int J Surg, 13, 71-5. https://doi.org/10.1016/j.ijsu.2014.11.029
  25. Ong CK, Chan SY, Campo MS, et al (1993). Evolution of human papillomavirus type 18: an ancient phylogenetic root in Africa and intratype diversity reflect coevolution with human ethnic groups. J Virol, 67, 6424-31.
  26. Pimhanam C, Sangrajrang S, Ekpanyaskul C (2014). Tobacco smoke exposure and breast cancer risk in Thai urban females. Asian Pac J Cancer Prev, 15, 7407-11. https://doi.org/10.7314/APJCP.2014.15.17.7407
  27. Proctor E, Kidwell KM, Jiagge E, et al (2015). Characterizing Breast Cancer in a Population with Increased Prevalence of triple-negative breast cancer: androgen receptor and ALDH1 expression in ghanaian women. Ann Surg Oncol.
  28. Sigaroodi A, Nadji SA, Naghshvar F, et al (2012). Human papillomavirus is associated with breast cancer in the north part of Iran. Scientific World J, 2012.
  29. Tahmasebi fard Z (2013). The relationship between Human Papillomavirus and Epstein-Barr virus infections with breast cancer of Iranian patients. Res Molecular Med, 1, 37-41.
  30. Tazhibi M, Feizi A (2014). Awareness Levels about Breast Cancer Risk Factors, Early Warning Signs, and Screening and Therapeutic Approaches among Iranian Adult Women: A large Population Based Study Using Latent Class Analysis. Bio Med Res Int, 2014.
  31. Tsai JH, Tsai CH, Cheng MH, et al (2005). Association of viral factors with non-familial breast cancer in Taiwan by comparison with non-cancerous, fibroadenoma, and thyroid tumor tissues. J Med Virol, 75, 276-81. https://doi.org/10.1002/jmv.20267
  32. Widschwendter A, Brunhuber T, Wiedemair A, et al (2004). Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. J Clin Virol, 31, 292-7. https://doi.org/10.1016/j.jcv.2004.06.009
  33. Yahia ZA, Adam AA, Elgizouli M, et al (2014). Epstein Barr virus: a prime candidate of breast cancer aetiology in Sudanese patients. Infect Agent Cancer, 9, 9. https://doi.org/10.1186/1750-9378-9-9
  34. Zandberg DP, Bhargava R, Badin S, et al (2013). The role of human papillomavirus in nongenital cancers. CA Cancer J Clin, 63, 57-81. https://doi.org/10.3322/caac.21167